Ground News

institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Novo Nordisk image

News about Novo Nordisk

Stay current with all the latest and breaking news about Novo Nordisk, compare headlines and perspectives between news sources on stories happening today. In total, 133stories have been published about Novo Nordisk which Ground News has aggregated in the past 3 months.

Covered Most By

Team Novo Nordisk

Suggest a source

Local News Publishers

Suggest a source

Looking for a source we don't already have? Suggest one here.

Top Novo Nordisk News

Novo Nordisk ends deal with Hims & Hers over sales of Wegovy copycats; HIMS drops 20%

Novo Nordisk · United States

Novo Nordisk ends deal with Hims & Hers over sales of Wegovy copycats; HIMS drops 20%

62% Center coverage: 73 sources

Collaboration of over one month has ended based on Hims & Hers deceptive promotion and selling of illegitimate, knockoff versions of Wegovy® that put patient...See the Story

Patients deserve easy access to innovative obesity drugs

Obesity · College Station

Patients deserve easy access to innovative obesity drugs

89% Center coverage: 27 sources

Insulin changed the way we treat and manage diabetes. Chemotherapy has precipitously reduced the mortality rate of certain cancers.See the Story

Study Claims Ozempic May Also Help Reduce Dementia Risk

Alzheimer's Disease

Study Claims Ozempic May Also Help Reduce Dementia Risk

50% Center coverage: 18 sources

Researchers found that the active ingredient in Ozempic may lower the risk of dementia in people with type 2 diabetes.See the Story

Terry Smith Blasts Novo, Coloplast in Danish Life Science Rebuke

100% Left coverage: 1 sources

Terry Smith slammed two of Denmark’s largest life sciences companies — Novo Nordisk A/S and Coloplast A/S — after they weighed on the equity fund run by the man often dubbed ‘Britain’s Warren Buffett.’Warren Buffett · Denmark Read Article

Novo Nordisk Says WeightWatchers Will Sell Wegovy, Announces US$299 Price

60% Center coverage: 5 sources

Novo Nordisk said on Thursday it will collaborate with WeightWatchers to sell its blockbuster weight-loss drug Wegovy, starting July 1.Wegovy See the Story

Moody Aldrich Partners LLC Makes New Investment in Novo Nordisk A/S (NYSE:NVO)

Moody Aldrich Partners LLC acquired a new position in Novo Nordisk A/S (NYSE:NVO – Free Report) in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 2,916 shares of the company’s stock, valued at approximately $202,000. Other institutional investors have also added to or reduced […]Novo Nordisk · Denmark Read Article

Swiss insurers fear cost explosion from weight loss drug

Since March 2024, Switzerland’s basic health insurance started reimbursing part of the cost of Wegovy, a weight-loss drug developed by Danish pharmaceutical giant Novo Nordisk. The decision has led to a surge in uptake—and concern among insurers, reported RTS. Roughly 40,000 people received Wegovy under Switzerland’s mandatory health insurance in 2024, according an association representing […]Wegovy · Switzerland See the Story

Harbour Trust & Investment Management Co Purchases 22,195 Shares of Novo Nordisk A/S (NYSE:NVO)

100% Center coverage: 1 sources

Harbour Trust & Investment Management Co boosted its position in Novo Nordisk A/S (NYSE:NVO - Free Report) by 26.1% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 107,261 shares of the company's stock after purchasing an additional 22,195 shares duNovo Nordisk · Denmark Read Article

Novo Nordisk A/S (NYSE:NVO) Receives Consensus Recommendation of "Hold" from Analysts

100% Center coverage: 1 sources

Novo Nordisk A/S (NYSE:NVO - Get Free Report) has earned a consensus recommendation of "Hold" from the eleven research firms that are presently covering the stock, Marketbeat reports. Two research analysts have rated the stock with a sell rating, five have assigned a hold rating, three have givenNovo Nordisk · Denmark Read Article

How Novo Nordisk Misread the US Market for Its Weight Loss Sensation – RamaOnHealthcare

COPENHAGEN (Reuters) -Novo Nordisk's top executives ignored internal warnings that the company was not sufficiently prepared for the launch of itsPharma · Denmark See the Story

Lot of diabetes, weight loss drug Ozempic recalled in Canada

Coverage: 2 sources

Novo Nordisk Canada has issued a voluntary recall for a lot of its semaglutide injection pens Ozempic due to potential cracked glass cartridges. The recalled cartridge strength is 1mg 3mL and its lot number is RZFFE55.Health Canada · Canada See the Story

Breaking News Topics Related to Novo Nordisk

Our use of cookiesCookie policy

Unlike other news sites, we do not share or sell your data to third-parties for targeted ads. In fact, the Ground News application and website do not run any ads at all. Our application and website use cookies and similar technologies to personalize content we deliver to you and also allows us to improve your usage of our platform through analytics. These cookies help us provide the best experience possible. Learn more about cookies and preference selection here.

By continuing to use our application or website, you agree to our Terms of Service and Privacy Policy.